Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hideo Oishi, MD"'
Autor:
Takashi Araki, MD, Ryota Morimoto, MD, PhD, Ryota Ito, MD, Takashi Mizutani, MD, Yuki Kimura, MD, Shingo Kazama, MD, Hideo Oishi, MD, Tasuku Kuwayama, MD, PhD, Hiroaki Hiraiwa, MD, PhD, Toru Kondo, MD, PhD, Takahiro Okumura, MD, PhD, Toyoaki Murohara, MD, PhD
Publikováno v:
CJC Open, Vol 4, Iss 7, Pp 656-659 (2022)
A 53-year-old woman with no significant medical history developed cardiogenic shock 4 days after receiving the second dose of the COVID-19 mRNA vaccine (BNT162b2, Pfizer/BioNtech). The patient required extracorporeal membrane oxygenation and an Impel
Externí odkaz:
https://doaj.org/article/ef9fc33d85a14cb796a643fde00aa09b
Autor:
Shingo Kazama, MD, Takahiro Okumura, MD, PhD, Yuki Kimura, MD, Ryota Ito, MD, Takashi Araki, MD, Takashi Mizutani, MD, Hideo Oishi, MD, Tasuku Kuwayama, MD, PhD, Hiroaki Hiraiwa, MD, PhD, Toru Kondo, MD, PhD, Ryota Morimoto, MD, PhD, Tomoaki Saeki, MD, PhD, Toyoaki Murohara, MD, PhD
Publikováno v:
CJC Open, Vol 4, Iss 5, Pp 501-505 (2022)
A 48-year-old woman suffered from cardiogenic shock with fulminant myocarditis following the second dose of COVID-19 vaccine (mRNA-1273). Venoarterial extracorporeal membrane oxygenation and Impella support were essential in achieving hemodynamic sta
Externí odkaz:
https://doaj.org/article/0fa619d7b84a4baaac4816354159bc97
Autor:
Hideo Oishi, MD, Ryota Morimoto, MD, PhD, Yoshie Shimoyama, MD, PhD, Kei Kuroda, MD, Toru Urata, MD, Toru Kondo, MD, PhD, Takahiro Okumura, MD, PhD, Yasuko K. Bando, MD, PhD, Masashi Akiyama, MD, PhD, Toyoaki Murohara, MD, PhD
Publikováno v:
JACC: Case Reports, Vol 2, Iss 12, Pp 1937-1941 (2020)
Recent developments in immune checkpoint inhibitors (ICIs) have provided new treatment strategies for advanced cancer. However, ICIs lead to an imbalance between T cell–mediated inflammatory responses and immune tolerance in the myocardium. Here we
Externí odkaz:
https://doaj.org/article/610d46b3de8442eca223088324d70def